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1734 Abstracts December 2013Methods: The patient is a 65-year-old male who presented with right
arm and face weakness associated with severe coughing ﬁts. Carotid duplex
revealed moderate stenosis of the right internal carotid artery and a total
occlusion of the left common and internal carotid arteries. This was
conﬁrmed by computed tomography angiogram, which also revealed absent
posterior communicating arteries bilaterally. A right carotid and cerebral
angiogram demonstrated minimal perfusion of the left cerebral hemisphere
through a small anterior communicating artery. A selective angiogram of the
left subclavian artery showed reconstitution of the left external carotid
artery, which communicated with the intracranial left internal carotid artery
through anastomoses between the infraorbital branch of the inferior maxil-
lary artery and the ophthalmic branch of the internal carotid artery (black
arrows in Fig). The patient underwent left subclavian to external carotid
artery bypass with reversed saphenous vein.
Results: Immediately postoperatively, the patient had complete reso-
lution of his right sided weakness that occurred during coughing ﬁts. He has
not had any recurrent symptoms over 9 months of follow-up.
Conclusions: Cough-induced hemispheric TIA is rarely described.
Similar to the physiology underlying cough-syncope, transiently increased
intracranial pressure and decreased venous return associated with coughing
likely decreases the collateral circulation to the affected hemisphere.
Although many patients with hemodynamic TIA or stroke are medically
managed with permissive hypertension, revascularization of the external
carotid artery is also an important treatment option in select patients.
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Objectives: Prior analysis has demonstrated that survival, quality of
life, and total healthcare costs are not signiﬁcantly different between the
two methods of repair of abdominal aortic aneurysm (AAA) in the Open
Versus Endovascular Repair Veterans Affairs (VA) Cooperative Study.
The device is a substantial portion of the cost of this method of repair,
and the objective of this study is to evaluate the costs of AAA repair and
total healthcare costs when different endograft systems are selected for the
endovascular repair.
Methods: Eight hundred and eighty-one subjects were randomized
to open (437) or endovascular repair (444). Device selection was recorded
before randomization; therefore open repair controls are matched to each
device cohort. Data was excluded for two low volume devices, implanted
in only 13 subjects. Mean device, hospitalization, and total healthcare costs
from randomization to two years were compared. Health care utilization
data were obtained from patients and national VA and Medicare data sour-
ces. VA costs were determined using methods previously developed by the
VA Health Economics Resource Center. Non-VA costs were obtained from
Medicare claims data and billing data from the patient’s healthcare
providers.
Results: Implant costs are 38% of initial hospitalization costs. Mean
device, initial hospitalization and total health care costs at two years in the
endovascular and open repair groups are not signiﬁcantly different between
device systems. Differences between endovascular and corresponding open
repair cohorts show lower mean costs for endovascular repair but these are
not statistically different.
Conclusions: Endovascular aneurysm repair implant costs are
substantial. When evaluating total healthcare system expenditures, there is
large individual variability in costs, and there is no signiﬁcant difference at
two years between systems or when an individual system is compared to
open repair.Table. Mean costs of AAA repair
EVR device (n ¼ 431) mean costs (SD) Zenith (n ¼ 166)
Implant 14,395 (2552)
Initial hospitalization 38,141 (27517)
Total at 2 years 78,198 (60216)
Open repair (n ¼ 423) (n ¼ 175)
Total at 2 years 82,069 (113783)
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Objectives: Lysyl oxidase (LOX) initiates the covalent cross-linking of
elastin and collagen in wound healing and has been shown to increase in
vascular lesions postintervention. We have previously demonstrated
dysfunctional matrix metalloproteinase regulation in hormone replacement
therapy (HRT)-modulated intimal hyperplasia (IH). Likewise, we hypothe-
size that LOX plays a role in HRT-mediated IH. Here we investigated the
effect of estrogen and progesterone on LOX expression in vitro and in vivo.
Methods: Human vascular smooth muscle cells (VSMCs) were
treated with estrogen (Est; 0-500 nM), progesterone (Prog; 0-5000
nM) or a combination of Est and Prog at a ratio of 1:10 (EP) for 24
hours. LOX expression and the expression of its homologs LOXL1,
LOXL2, and LOXL3 were measured by qPCR normalized to 18S. Aged
ovariectomized (OVX) female rats were implanted with slow-release Est
(0.72 mg), Prog (200 mg), combination (EP), or placebo (Plac) pellets
and 6 weeks later underwent carotid artery balloon angioplasty. Vessels
were stained 14 days postinjury with Trichrome-elastin and LOX-speciﬁc
antibodies. Intima:media (I:M) ratios were used to measure degree of
IH development, and tissue levels of LOX were quantiﬁed as percent
area stained.
Results: I:M signiﬁcantly decreased in OVX rats receiving Plac vs
non-OVX controls. I:M slightly increased in OVX animals receiving Est,
Prog, and EP vs Plac (Table). While Est alone had no effect on the expres-
sion of LOX in vitro, EP combination signiﬁcantly decreased the expression
of LOX and all LOX homologs in a dose dependent manner (Fig).
Conversely, EP combination therapy signiﬁcantly increased LOX expression
in vivo (Table).
Conclusions: EP combination therapy differentially regulates LOX in
vitro and in vivo. The upregluation of LOX in vivo may be attributed to
macrophage inﬁltration in response to injury or the milieu of multiple cell
types present in whole vascular tissue. Thus, cell types other than VSMCs
should be examined for their regulatory effect of LOX. While LOX expres-
sion may be playing a role in EP-mediated IH, other mechanisms should be
investigated to delineate the role of HRT in IH development.Excluder (n ¼ 177) AneuRx (n ¼ 88) P value
13,582 (3820) 14,262 (4191) .08
34,804 (31206) 38,942 (24874) .43
73,458 (65123) 72,438 (42389) .68
(n ¼ 150) (n ¼ 98)
81,791 (84488) 75,591 (84061) .85
.33 .74
